United States · FDA National Drug Code directory

PANTOPRAZOLE SODIUM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68788-8644_b7c006b5-a176-4266-a076-e49595cc7266
Product NDC
68788-8644
Form
TABLET, DELAYED RELEASE
Composition / generic term
PANTOPRAZOLE
Labeler
Preferred Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20240501
Source listing expiry
20271231

Source-listed ingredients

  • PANTOPRAZOLE SODIUM — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8644-1) · 68788-8644-1
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8644-3) · 68788-8644-3
  • 60 TABLET, DELAYED RELEASE in 1 CARTON (68788-8644-6) · 68788-8644-6
  • 120 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8644-8) · 68788-8644-8
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (68788-8644-9) · 68788-8644-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →